Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 3 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 3

From: Diffusion-weighted MR imaging diagnostic merits in the post-therapeutic assessment of musculoskeletal soft tissue sarcoma

Fig. 3

A 50-year-old male patient presenting with right lumbar pleomorphic RMS. Contrast-enhanced T1-weighted images at baseline, 10 and 17 weeks after chemotherapy (a–c) revealing heterogeneous moderately enhancing mass with size progression in follow up exams. There was about (35%) increase in size as compared to the initial study which is classified as PD according to RECIST and m RECIST. ADC images at baseline, after 10 weeks of chemotherapy and after 17 weeks (d–f) showing decrease of the mean ADC value of the tumor along with the first and second follow-ups

Back to article page